feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Man City defeats Liverpool

trending

Olympiacos Panathinaikos Greek Super League

trending

Leverkusen draw stops winning streak

trending

PSG vs Marseille live stream

trending

Real Madrid vs Valencia live

trending

Yildiz extends Juventus contract

trending

Benfica aims to strengthen position

trending

Everton beat AFC Bournemouth

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / UK DES victims urge public inquiry for historic drug harm

UK DES victims urge public inquiry for historic drug harm

9 Feb

•

Summary

  • DES victims to meet Health Secretary Wes Streeting for inquiry
  • Campaign group seeks NHS screening for DES exposure risks
  • DES, a pregnancy drug from 1940-70s, linked to cancers and infertility
UK DES victims urge public inquiry for historic drug harm

Victims of the pregnancy drug diethylstilbestrol (DES) are scheduled to meet with Health Secretary Wes Streeting. The group, DES Justice UK (DJUK), is advocating for a public inquiry into the widespread use of the drug, which was prescribed to approximately 300,000 pregnant women between the 1940s and 1970s.

DJUK, comprising over 500 members including women and their descendants, also seeks the establishment of an NHS screening program. This program aims to identify individuals who may face health risks, such as infertility, reproductive abnormalities, and an increased likelihood of certain cancers, due to DES exposure. The drug was linked to clear cell adenocarcinoma in 1971, leading to warnings in the US, though it continued to be used in Europe until 1978.

Health Secretary Wes Streeting previously apologized to victims, acknowledging that 'the state got it wrong.' He urged those affected to consult their GPs. Susie Martin, whose mother took DES, shared her extensive personal suffering, including numerous operations and ongoing health anxieties. She emphasized the need for concrete action beyond meetings, specifically a screening program and a full statutory public inquiry.

Clare Fletcher, representing DJUK, stressed that this is one of the UK's most significant pharmaceutical scandals. She highlighted that victims continue to suffer today, making it a current injustice rather than a purely historical one. Unlike the US and Netherlands, the UK currently lacks a compensation scheme for DES victims, a gap DJUK aims to address through their advocacy for justice and fair treatment for those affected.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The DES scandal involves victims of the pregnancy drug diethylstilbestrol (DES), which was prescribed from the 1940s to 1970s and is linked to cancers and reproductive issues. Victims are demanding a public inquiry to address the historical use and ongoing impact of the drug.
DES Justice UK is urging the Health Secretary to launch a public inquiry into the DES scandal and to establish an NHS screening program to identify individuals at risk from exposure to the drug.
DES exposure is linked to clear cell adenocarcinoma (a cancer of the cervix and vagina), as well as other cancers like breast and pancreatic cancer. It has also caused infertility and reproductive abnormalities in descendants of women who took the drug.

Read more news on

Healthside-arrow

You may also like

Sepsis Survivor Denied Breast Reduction

6 Feb • 13 reads

article image

BMA Doctors Back Further NHS Action

2 Feb • 45 reads

article image

Doctor Warns of Hidden Dangers in Supplement Overdosing

26 Jan • 90 reads

article image

NHS Strike: Government Makes Play to Halt Christmas Walkout

11 Dec, 2025 • 326 reads

article image

NHS Chief: Mask Up or Spread the Flu!

10 Dec, 2025 • 329 reads

article image